Arysta LifeScience Names New Head of Europe, Middle East & Africa
CARY, N.C. (21 November 2017) – Arysta LifeScience, a Platform Specialty Products Company (NYSE: PAH), recently named Hildo Brilleman as the company’s chief executive officer of its Europe, Middle East & Africa (EMEA) region, effective January 1, 2018.
“In his years in the ag industry, Hildo has assembled an impressive track record of building successful teams and businesses, proving himself to be an entrepreneurial leader,” said Diego Lopez Casanello, President, Arysta LifeScience. “In addition, his experience working in Europe, Africa and the Americas brings a truly international perspective to the position, which is especially important in a region that spans three continents.”
Brilleman has been with Arysta LifeScience for nearly nine years. His recent contributions as Head of Northwest, Central and Eastern Europe have been a fundamental part of EMEA’s success in the past several years. Earlier in his Arysta LifeScience career, Brilleman worked in marketing and commercial management and as a global marketing manager for Herbicides and Fumigants, leading multiple new product launches and business development and marketing projects. Prior to joining Arysta LifeScience, he gained experience with Hoya Vision Care Europe and Syngenta. Brilleman holds a bachelor’s degree from Nyenrode University in the Netherlands and a master’s degree from the University of Leuven in Belgium, both in business administration.
About Arysta LifeScience
Arysta LifeScience is a global agricultural company specializing in the marketing and distribution of innovative crop protection and life science brands. With more than 200 active ingredients, Arysta LifeScience has a well-integrated biological and chemical portfolio to provide complete solutions to growers. The company’s wide range of offerings includes biosolutions, fungicides, herbicides, insecticides and seed treatments. Arysta LifeScience, which has more than 3,000 employees working in 60 countries to serve customers worldwide, had 2016 revenues of US$1.8 billion. Arysta LifeScience is owned by Platform Specialty Products Corporation (NYSE:PAH), a global innovator of technologically advanced specialty chemical products and provider of technical services (www.platformspecialtyproducts.com). For more information on Arysta LifeScience, visit www.arystalifescience.com.
Global & North America Communications